ArticleBMC pediatrics2025
Red blood cell transfusion frequency and the risk and severity of bronchopulmonary dysplasia in preterm infants: a retrospective cohort study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of iron sufficiency in premature infants treated with darbepoetin using conventional and novel erythrocyte metrics.Journal of perinatology : official journal of the California Perinatal Association · 2026Article
- Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial.Transfusion · 2026Article
- Incidence and factors associated with bronchopulmonary dysplasia: a cohort study in a high-risk Colombian neonatal intensive care unit.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRed blood cell (RBC) transfusion is a common intervention for anemia in preterm infants; however, its association with bronchopulmonary dysplasia (BPD) remains debated. While biological mechanisms suggest potential harm, the clinical impact of transfusion frequency on BPD incidence and severity remains unclear.
objectiveTo investigate whether RBC transfusion frequency is independently associated with the risk and severity of BPD in preterm infants born before 32 weeks of gestation.
methodsThis retrospective cohort study included preterm infants (< 32 weeks gestational age) admitted to the NICU at Zhangzhou Affiliated Hospital of Fujian Medical University between January 2020 and December 2022. Only transfusions administered before 36 weeks postmenstrual age were included. Clinical data, including transfusion frequency, hemoglobin levels, and respiratory diagnoses, were collected. Logistic regression was used to identify independent risk factors for BPD, and ROC curve analysis determined the optimal transfusion threshold. Subgroup and sensitivity analyses were conducted to evaluate confounding effects.
resultsAmong 228 included infants, 184 (80.7%) received at least one RBC transfusion. The BPD group received a higher number of transfusions (mean 4.24 vs. 1.89, p < 0.001). Multivariate analysis identified transfusion frequency (OR = 1.245; 95% CI: 1.023-1.514; p = 0.049) and lower gestational age (OR = 0.749; 95% CI: 0.561-0.998; p = 0.05) as independent risk factors for BPD. ROC analysis demonstrated transfusion frequency effectively predicted BPD (AUC = 0.749), with ≥ 4 transfusions (sensitivity 51%, specificity 77%) correlating with increased severity (Kendall's τ_b = 0.453, p < 0.001). Neonatal hemoglobin levels inversely correlated with transfusion requirements (r=-0.187, p < 0.001). Subgroup analysis confirmed this association across GA strata (p < 0.05). Early transfusion (≤ 14 days of life) was not associated with increased severity.
conclusionRBC transfusion frequency is an independent, dose-dependent risk factor for BPD in preterm infants. Reducing unnecessary transfusions and optimizing anemia management may help mitigate BPD risk and severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.